MediWound (MDWD) Common Equity (2013 - 2025)
MediWound (MDWD) posted quarterly Common Equity of $43.6 million for Q4 2025, up 40.06% year-over-year from $31.2 million in Q4 2024, and down 13.01% quarter-over-quarter from $50.2 million in Q3 2025.
MediWound (MDWD) Common Equity (2013 - 2025) Analysis & Trends
MediWound's Common Equity history runs 13 years deep, the most recent figure standing at $43.6 million for Q4 2025.
- In Q4 2025, Common Equity rose 40.06% year-over-year to $43.6 million; the TTM figure through Dec 2025 stood at $43.6 million (up 40.06% YoY), while the FY2025 annual figure was $43.6 million, up 40.06% from the prior year.
- Common Equity for Q4 2025 stood at $43.6 million, down from $50.2 million in the prior quarter.
- The five-year high for Common Equity was $50.2 million in Q3 2025, with the low at -$4.6 million in Q4 2021.
- The 5-year median for Common Equity is $21.7 million (2024), against an average of $19.9 million.
- The sharpest annual moves came in 2022 and 2023: Common Equity tumbled 205.52% in 2022, then soared 1895.77% in 2023.
- MediWound's Common Equity stood at -$4.6 million in 2021, then jumped by 338.19% to $10.9 million in 2022, then soared by 189.49% to $31.6 million in 2023, then decreased by 1.4% to $31.2 million in 2024, then soared by 40.06% to $43.6 million in 2025.
- Business Quant data shows MDWD's Common Equity at $43.6 million in Q4 2025, $50.2 million in Q3 2025, and $20.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | 9.79 Bn |
| 10 | MediWound | 170.84 Mn | 139.84 Mn | 337,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.63 Mn |
| Sep 30, 2025 | 50.16 Mn |
| Jun 30, 2025 | 20.12 Mn |
| Mar 31, 2025 | 31.27 Mn |
| Dec 31, 2024 | 31.15 Mn |
| Sep 30, 2024 | 34.24 Mn |
| Jun 30, 2024 | 17.87 Mn |
| Mar 31, 2024 | 23.20 Mn |
| Dec 31, 2023 | 31.60 Mn |
| Sep 30, 2023 | 33.05 Mn |
| Jun 30, 2023 | 34.93 Mn |
| Mar 31, 2023 | 33.30 Mn |
| Dec 31, 2022 | 10.91 Mn |
| Sep 30, 2022 | 1.66 Mn |
| Jun 30, 2022 | -2.24 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | -4.58 Mn |
| Sep 30, 2021 | -821,000.00 |
| Jun 30, 2021 | 2.12 Mn |
| Mar 31, 2021 | 4.82 Mn |